Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117223

Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.

A Bergamini, M Capozzi, L Ghibelli, L Dini, A Salanitro, G Milanese, T Wagner, S Beninati, C D Pesce, and C Amici

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Bergamini, A. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Capozzi, M. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Ghibelli, L. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Dini, L. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Salanitro, A. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Milanese, G. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Wagner, T. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Beninati, S. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Pesce, C. in: PubMed | Google Scholar

Department of Public Health, University of Rome Tor Vergata, Italy.

Find articles by Amici, C. in: PubMed | Google Scholar

Published May 1, 1994 - More info

Published in Volume 93, Issue 5 on May 1, 1994
J Clin Invest. 1994;93(5):2251–2257. https://doi.org/10.1172/JCI117223.
© 1994 The American Society for Clinical Investigation
Published May 1, 1994 - Version history
View PDF
Abstract

We have investigated the effects of cystamine on the replication of human immunodeficiency virus (HIV) in human lymphocytes and macrophages, the natural targets of HIV in vivo. Treatment of chronically infected macrophages with cystamine, at a concentration (500 microM) that did not show any cytotoxic or cytostatic effects, strongly decreased (> 80%) HIV-p24 antigen production and completely abolished the production of infectious viral particles. Cystamine does not affect viral transcription, translation or protein processing; indeed, all HIV proteins are present in a pattern similar to that of nontreated cells. Instead, cystamine interferes with the orderly assembly of HIV virions, as shown by electron microscopy analysis, that reveals only defective viral particles in treated cells. Moreover, suppression of HIV replication, due to the inhibition of proviral DNA formation was observed in acutely infected lymphocytes and macrophages pretreated with cystamine. These results show that cystamine potently suppresses HIV replication in human cells by contemporaneously blocking at least two independent steps of the viral life cycle, without affecting cell viability, suggesting that this compound may represent a new possibility towards the treatment of HIV-1 infection.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2251
page 2251
icon of scanned page 2252
page 2252
icon of scanned page 2253
page 2253
icon of scanned page 2254
page 2254
icon of scanned page 2255
page 2255
icon of scanned page 2256
page 2256
icon of scanned page 2257
page 2257
Version history
  • Version 1 (May 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts